Opus Genetics amends CEO and CFO employment agreements; enhances severance upon Change in Control

Opus Genetics, Inc.

CEO Magrath severance multiple raised to 1.5x salary+target bonus on CIC termination; COBRA extended to 18 months.
CFO Jhaveri severance multiple raised to 1.0x salary+target bonus; COBRA extended to 12 months.
Magrath also gets prorated target bonus for non-CIC qualifying termination.
Jhaveri's enhanced sever eligibility expanded to include 3 months prior to a Change in Control.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.